Bloomios, Inc.
OTC: BLMS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Michael Hill
- Employees
- 23
- Headquarters
- Santa Barbara, United States
- IPO year
- 2003
- Market cap
- $6.4K
- Website
- https://www.bloomios.com
Loading BLMS…
Loading profile data…Frequently asked questions about BLMS
What does Bloomios, Inc. (BLMS) do?
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company’s product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerl...
Where does BLMS trade?
Bloomios, Inc. (BLMS) trades on the Other OTC.
What sector is BLMS in?
Bloomios, Inc. (BLMS) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Bloomios, Inc.?
Michael Hill is the chief executive officer of Bloomios, Inc. (BLMS).
Where is Bloomios, Inc. headquartered?
Bloomios, Inc. is headquartered in United States.
Does BLMS pay a dividend?
Bloomios, Inc. (BLMS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BLMS go public?
Bloomios, Inc. (BLMS) completed its initial public offering in 2003.